Monjuvi

Armed with Phase III win, Incyte eyes label expansion for Monjuvi
Clinical Trials Arena
Fri, 08/16/24 - 11:19 am
Incyte
clinical trials
Monjuvi
relapsed or refractory follicular lymphoma
OptumRx's 3 recently approved drugs to watch
Beckers Hospital Review
Tue, 09/22/20 - 10:15 pm
FDA
Kite Pharma
Tecartus
Novartis
Kesimpta
MorphoSys
Monjuvi
OptumRx
FDA approves MorphoSys, Incyte’s drug for vulnerable lymphoma population
MedCity News
Mon, 08/3/20 - 10:14 am
FDA
Monjuvi
CAR-T
MorphoSys
Incyte
diffuse large B-cell lymphoma